Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Platelet Associated Igg May Be Related With Thrombocytopenia In Patients With Myelodysplastic Syndromes.

Gilli, Simone Cristina Olenscki
de Souza Medina, Samuel
de Castro, Vagner
Fernandes, Luís Gustavo Romani
Saad, Sara Teresinha Olalla

November 2015

Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction o...

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

de Witte, Theo
Malcovati, Luca
Fenaux, Pierre
Bowen, David
Symeonidis, Argiris
Mittelman, Moshe
Stauder, Reinhard
Sanz, Guillermo
Čermák, Jaroslav
Langemeijer, Saskia
Hellström-Lindberg, Eva
Germing, Ulrich
Skov Holm, Mette
Mądry, Krzysztof
Tatic, Aurelia
Medina Almeida, António
Savic, Aleksandar
Mandac Rogulj, Inga
Itzykson, Raphael
Hoeks, Marlijn
Gravdahl Garelius, Hege
Culligan, Dominic
Kotsianidis, Ioannis
Ades, Lionel
van de Loosdrecht, Arjan A.
van Marrewijk, Corine
Yu, Ge
Crouch, Simon
Smith, Alex

November 2020

Available evidence suggests that in most patients with LR-MDS the risk of death is not related to di...

A STUDY OF THE PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE LEVELS IN MYELODYSPLASTIC SYNDROME

Praveen Malayath

December 2017

BACKGROUND Myelodysplastic syndromes are clonal marrow stem cell disorders characterised by ineffec...

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.

Itzykson R
Crouch S
Travaglino E
Smith A
Symeonidis A
Hellström-Lindberg E
Sanz G
Čermák J
Stauder R
Elena C
Germing U
Mittelman M
Langemeijer S
Mądry K
Tatic A
Holm MS
Almeida AM
Savic A
Šimec NG
Luño E
Culligan D
Guerci-Bresler A
Malcovati L
van Marrewijk C
Bowen D
de Witte T
Fenaux P

January 2018

Prognosis of lower-risk (International Prognostic Scoring System [IPSS] low/intermediate-1) myelodys...

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

Swart, L. de
Crouch, S.
Hoeks, M.P.A.
Smith, A.
Langemeijer, S.M.
Fenaux, P.
Marrewijk, C.J. van
Blijlevens, N.M.
Bowen, D.
de Witte, T.J.

January 2020

Contains fulltext : 217356.pdf (publisher's version ) (Open Access

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Swart, L. de
Reiniers, Chloe
Bagguley, Timothy
Marrewijk, C.J. van
Bowen, D.
Hellstrom-Lindberg, E.
Blijlevens, N.M.
Langemeijer, S.M.C.
Droste, J.A.H.
Swinkels, D.W.
Smith, A.
Witte, T.J.M. de

January 2018

Contains fulltext : 183944.pdf (publisher's version ) (Open Access

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Itzykson, Raphael
Crouch, Simon
Travaglino, Erica
Symeonidis, Argiris
Hellström-Lindberg, Eva
Sanz, Guillermo
Čermák, Jaroslav
Stauder, Reinhard
Elena, Chiara
Germing, Ulrich
Mittelman, Moshe
Langemeijer, Saskia
Mądry, Krzysztof
Tatic, Aurelia
Holm, Mette Skov
Almeida, Antonio Medina
Savic, Aleksandar
Šimec, Njetočka Gredelj
Luño, Elisa
Culligan, Dominic
Guerci-Bresler, Agnes
Malcovati, Luca
van Marrewijk, Corine
Bowen, David
de Witte, Theo
Fenaux, Pierre
Smith, Alexandra Gwen

August 2018

Prognosis of lower-risk (International Prognostic Scoring System [IPSS] low/intermediate-1) myelodys...

Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application.

Bowen, D.T.
Fenaux, P.
Hellstrom-Lindberg, E.
Witte, T.J.M. de

January 2008

Contains fulltext : 70608.pdf (publisher's version ) (Closed access

Immunophenotypic characteristics of platelets in patients with myelodysplastic syndrome and healthy controls.

Yi-Feng Wu (12130807)
Ming-Huei Gu (14149745)
Chao-Zong Liu (14149748)
Wei-Han Huang (2114248)
Sung-Chao Chu (9921936)
Tso-Fu Wang (9921933)

November 2022

Immunophenotypic characteristics of platelets in patients with myelodysplastic syndrome and healthy ...

Evaluation of platelet indices and morphology as possible biomarkers of prognostic value in myelodysplastic syndrome

Cadena Berdugo, Sara Alejandra

June 2022

Los síndromes mielodisplásicos están caracterizados como un trastorno clonal que se diagnostica por ...

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.

Kantarjian, H.
Fenaux, P.
Sekeres, M.A.
Becker, P.S.
Boruchov, A.
Bowen, D.
Hellstrom-Lindberg, E.
Larson, R.A.
Lyons, R.M.
Muus, P.
Shammo, J.
Siegel, R.
Hu, K.
Franklin, J.
Berger, D.P.

January 2010

Item does not contain fulltextPURPOSE: To assess the safety and efficacy of romiplostim, a peptibody...

The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

Lorand-Metze, I
Califani, SMV
Ribeiro, E
Lima, CSP
Metze, K

November 2015

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...

Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes

Gilli, SCO
Medina, SD
de Castro, V
Fernandes, LGR
Saad, STO

November 2015

Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction o...

The Prognostic Value Of Maturation-associated Phenotypic Abnormalities In Myelodysplastic Syndromes.

Lorand-Metze, I
Califani, S M V
Ribeiro, E
Lima, C S P
Metze, K

November 2015

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

Fenaux, P.
Muus, P.
Kantarjian, H.
Lyons, R.M.
Larson, R.A.
Sekeres, M.A.
Becker, P.S.
Orejudos, A.
Franklin, J.

January 2017

Contains fulltext : 177251.pdf (publisher's version ) (Open Access)Romiplostim can...

Platelet Associated Igg May Be Related With Thrombocytopenia In Patients With Myelodysplastic Syndromes.

Gilli, Simone Cristina Olenscki
de Souza Medina, Samuel
de Castro, Vagner
Fernandes, Luís Gustavo Romani
Saad, Sara Teresinha Olalla

November 2015

Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction o...

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

de Witte, Theo
Malcovati, Luca
Fenaux, Pierre
Bowen, David
Symeonidis, Argiris
Mittelman, Moshe
Stauder, Reinhard
Sanz, Guillermo
Čermák, Jaroslav
Langemeijer, Saskia
Hellström-Lindberg, Eva
Germing, Ulrich
Skov Holm, Mette
Mądry, Krzysztof
Tatic, Aurelia
Medina Almeida, António
Savic, Aleksandar
Mandac Rogulj, Inga
Itzykson, Raphael
Hoeks, Marlijn
Gravdahl Garelius, Hege
Culligan, Dominic
Kotsianidis, Ioannis
Ades, Lionel
van de Loosdrecht, Arjan A.
van Marrewijk, Corine
Yu, Ge
Crouch, Simon
Smith, Alex

November 2020

Available evidence suggests that in most patients with LR-MDS the risk of death is not related to di...

A STUDY OF THE PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE LEVELS IN MYELODYSPLASTIC SYNDROME

Praveen Malayath

December 2017

BACKGROUND Myelodysplastic syndromes are clonal marrow stem cell disorders characterised by ineffec...

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.

Itzykson R
Crouch S
Travaglino E
Smith A
Symeonidis A
Hellström-Lindberg E
Sanz G
Čermák J
Stauder R
Elena C
Germing U
Mittelman M
Langemeijer S
Mądry K
Tatic A
Holm MS
Almeida AM
Savic A
Šimec NG
Luño E
Culligan D
Guerci-Bresler A
Malcovati L
van Marrewijk C
Bowen D
de Witte T
Fenaux P

January 2018

Prognosis of lower-risk (International Prognostic Scoring System [IPSS] low/intermediate-1) myelodys...

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

Swart, L. de
Crouch, S.
Hoeks, M.P.A.
Smith, A.
Langemeijer, S.M.
Fenaux, P.
Marrewijk, C.J. van
Blijlevens, N.M.
Bowen, D.
de Witte, T.J.

January 2020

Contains fulltext : 217356.pdf (publisher's version ) (Open Access

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Swart, L. de
Reiniers, Chloe
Bagguley, Timothy
Marrewijk, C.J. van
Bowen, D.
Hellstrom-Lindberg, E.
Blijlevens, N.M.
Langemeijer, S.M.C.
Droste, J.A.H.
Swinkels, D.W.
Smith, A.
Witte, T.J.M. de

January 2018

Contains fulltext : 183944.pdf (publisher's version ) (Open Access

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Itzykson, Raphael
Crouch, Simon
Travaglino, Erica
Symeonidis, Argiris
Hellström-Lindberg, Eva
Sanz, Guillermo
Čermák, Jaroslav
Stauder, Reinhard
Elena, Chiara
Germing, Ulrich
Mittelman, Moshe
Langemeijer, Saskia
Mądry, Krzysztof
Tatic, Aurelia
Holm, Mette Skov
Almeida, Antonio Medina
Savic, Aleksandar
Šimec, Njetočka Gredelj
Luño, Elisa
Culligan, Dominic
Guerci-Bresler, Agnes
Malcovati, Luca
van Marrewijk, Corine
Bowen, David
de Witte, Theo
Fenaux, Pierre
Smith, Alexandra Gwen

August 2018

Prognosis of lower-risk (International Prognostic Scoring System [IPSS] low/intermediate-1) myelodys...

Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application.

Bowen, D.T.
Fenaux, P.
Hellstrom-Lindberg, E.
Witte, T.J.M. de

January 2008

Contains fulltext : 70608.pdf (publisher's version ) (Closed access

Immunophenotypic characteristics of platelets in patients with myelodysplastic syndrome and healthy controls.

Yi-Feng Wu (12130807)
Ming-Huei Gu (14149745)
Chao-Zong Liu (14149748)
Wei-Han Huang (2114248)
Sung-Chao Chu (9921936)
Tso-Fu Wang (9921933)

November 2022

Immunophenotypic characteristics of platelets in patients with myelodysplastic syndrome and healthy ...

Evaluation of platelet indices and morphology as possible biomarkers of prognostic value in myelodysplastic syndrome

Cadena Berdugo, Sara Alejandra

June 2022

Los síndromes mielodisplásicos están caracterizados como un trastorno clonal que se diagnostica por ...

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.

Kantarjian, H.
Fenaux, P.
Sekeres, M.A.
Becker, P.S.
Boruchov, A.
Bowen, D.
Hellstrom-Lindberg, E.
Larson, R.A.
Lyons, R.M.
Muus, P.
Shammo, J.
Siegel, R.
Hu, K.
Franklin, J.
Berger, D.P.

January 2010

Item does not contain fulltextPURPOSE: To assess the safety and efficacy of romiplostim, a peptibody...

The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

Lorand-Metze, I
Califani, SMV
Ribeiro, E
Lima, CSP
Metze, K

November 2015

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...

Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes

Gilli, SCO
Medina, SD
de Castro, V
Fernandes, LGR
Saad, STO

November 2015

Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction o...

The Prognostic Value Of Maturation-associated Phenotypic Abnormalities In Myelodysplastic Syndromes.

Lorand-Metze, I
Califani, S M V
Ribeiro, E
Lima, C S P
Metze, K

November 2015

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

Fenaux, P.
Muus, P.
Kantarjian, H.
Lyons, R.M.
Larson, R.A.
Sekeres, M.A.
Becker, P.S.
Orejudos, A.
Franklin, J.

January 2017

Contains fulltext : 177251.pdf (publisher's version ) (Open Access)Romiplostim can...

Platelet Associated Igg May Be Related With Thrombocytopenia In Patients With Myelodysplastic Syndromes.

Gilli, Simone Cristina Olenscki
de Souza Medina, Samuel
de Castro, Vagner
Fernandes, Luís Gustavo Romani
Saad, Sara Teresinha Olalla

November 2015

Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction o...

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

de Witte, Theo
Malcovati, Luca
Fenaux, Pierre
Bowen, David
Symeonidis, Argiris
Mittelman, Moshe
Stauder, Reinhard
Sanz, Guillermo
Čermák, Jaroslav
Langemeijer, Saskia
Hellström-Lindberg, Eva
Germing, Ulrich
Skov Holm, Mette
Mądry, Krzysztof
Tatic, Aurelia
Medina Almeida, António
Savic, Aleksandar
Mandac Rogulj, Inga
Itzykson, Raphael
Hoeks, Marlijn
Gravdahl Garelius, Hege
Culligan, Dominic
Kotsianidis, Ioannis
Ades, Lionel
van de Loosdrecht, Arjan A.
van Marrewijk, Corine
Yu, Ge
Crouch, Simon
Smith, Alex

November 2020

Available evidence suggests that in most patients with LR-MDS the risk of death is not related to di...

A STUDY OF THE PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE LEVELS IN MYELODYSPLASTIC SYNDROME

Praveen Malayath

December 2017

BACKGROUND Myelodysplastic syndromes are clonal marrow stem cell disorders characterised by ineffec...

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Abstract

Extracted data

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Abstract

Extracted data

Related items

Related items